Are insiders buying Traws Pharma stock?

In the last 12 months, insiders at Traws Pharma bought $998,207 of stock and sold $0 across 31 Form 4 filings.

Who bought Traws Pharma stock recently?

The most recent insider purchase at Traws Pharma was by Orbimed Capital Gp VIII LLC (10%+), reported on April 29, 2026, with a transaction value of $998,207.

How many insiders sold Traws Pharma shares in the last year?

No insiders reported selling Traws Pharma shares in the last 12 months.

Traws Pharma (TRAW) Insider Trading

Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Traws Pharma.

Bought (12 mo) $998,207

Sold (12 mo) $0

Insiders Buying (12 mo) 2

Insiders Selling (12 mo) 0

Form 4 Filings (All Time) 113

Most Recent Purchase

April 29, 2026

Orbimed Capital Gp VIII LLC 10%+

$998,207

View all TRAW insider trades in the screener

Buys (90d) 0

Sells (90d) 0

Recent Insider Transactions

Recent insider transactions
Filed	Insider	Role	Type	Value	% Change